recent news

08/06/08 Achillion Announces Private Placement Financing for up to $41.5 Million
07/23/08 Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
07/02/08 Pearl Therapeutics Closes $18 Million Financing
05/14/08 TyRx Pharma, Inc. Announces the First Human Implant of the AIGIS RX™ Anti-Bacterial Envelope in Cardiac Patient
04/25/08 Astellas and Comentis Sign Agreement to Collaborate on the Research, Development and Commercialization of Beta-Secretase Inhibitors
4/01/08 Avanir Annouces Closing of $40 Million Registered Direct Offering
2/27/08 TyRx Pharma, Inc. Raises $25 Million in Private Financing
2/01/08 Taligen Therapeutics Secures Series B Financing
12/06/07 Pelikan Technologies closes $69 Million Series F Financing and secures a further $20 million in debt financing
10/29/07 Oxford Immunotec completes $40M Financing
9/06/07 Pearl Therapeutics Raises $15.5 Million in Private Financing
8/23/07 Globus Medical rasies $110 Million in Series E Financing Round
6/18/07 CoMentis Receives FDA Clearance to Begin Human Clinical Trials for its Disease-Modifying Alzheimer's Therapy
4/18/07 Aesthetics and Plastic Surgery Company Sientra Inc. Rasies $85 Million in Series B Financing
3/27/07 Aerovance Closes Second Tranche of $60 Million Series C Financing
2/07/07 Proacta Inc Completes $35M Series B Financing
1/04/07 Variation Biotechnologies Secures US$ 35.7 Million in Series A Financing to Fund Innovative Vaccine Platform
1/04/07 Aerovance Names Mark L. Perry President and CEO
1/03/07 Aerovance annouces Positive Top -Line Results from Phase 2a Trial of Inhaled AEROVANT™ in Asthma Patients
12/18/06 Aerovance adds Accomplished Product Commercialization Executive to Leadership Team
9/28/06 Athenagen Rasies $50 Million in Series B Financing
8/28/06
 8/02/06 ESBATech Closes CHF 50M ($41M) Series B Venture Financing
 5/04/06  Aerovance secures $60 M in Financing